Insider · CIK 0001585017
Jason Ryan
Files at WGS (GeneDx Holdings Corp.). First filing Nov 21, 2024, latest Aug 27, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WGS: GeneDx Holdings Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | GeneDx Holdings Corp. | $5.0M 39,222 shares | -28% | +266% from low0% from high | |
| 75Notable | GeneDx Holdings Corp. | $3.3M 47,000 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | 47,000 0.17% of outstanding | $3.3M | Nov 19, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan 2024 GRAT | -8,818 | $125.07 | $1.1M | 132,538 | Aug 27, 2025 |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan 2024 GRAT | -8,969 | $126.15 | $1.1M | 123,569 | Aug 27, 2025 |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan 2024 GRAT | -5,443 | $127.44 | $694k | 118,126 | Aug 27, 2025 |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan 2024 GRAT | -3,452 | $128.04 | $442k | 114,674 | Aug 27, 2025 |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan 2024 GRAT | -9,890 | $129.59 | $1.3M | 104,784 | Aug 27, 2025 |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan 2024 GRAT | -1,500 | $130.01 | $195k | 103,284 | Aug 27, 2025 |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,150 | $129.65 | $149k | 11,904 | Aug 27, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +12,924 | $0.00 | $0 | 13,054 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +3,576 | $0.00 | $0 | 3,576 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -12,924 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | GGift Class A Common Stockindirect: By Jason Ryan Trust u/a dtd 11/25/2018 | -141,356 | $0.00 | $0 | 47,000 | Nov 21, 2024 |
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan Trust u/a dtd 11/25/2018 | -5,952 | $70.86 | $422k | 41,048 | Nov 21, 2024 |
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan Trust u/a dtd 11/25/2018 | -24,784 | $71.35 | $1.8M | 16,264 | Nov 21, 2024 |
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan Trust u/a dtd 11/25/2018 | -774 | $72.26 | $56k | 15,490 | Nov 21, 2024 |
| Nov 20, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan Trust u/a dtd 11/25/2018 | -9,361 | $68.36 | $640k | 6,129 | Nov 21, 2024 |
| Nov 20, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan Trust u/a dtd 11/25/2018 | -1,857 | $69.84 | $130k | 4,272 | Nov 21, 2024 |
| Nov 20, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: By Jason Ryan u/a dtd 11/25/2018 | -4,272 | $70.50 | $301k | 0 | Nov 21, 2024 |
| Oct 15, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +130 | - | - | 73,744 | Oct 17, 2024 |
| Oct 15, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -130 | $0.00 | $0 | 0 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.